Management of Refractory OAB in the Non-Neurogenic Patient

Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?

(2013) Jai H. Seth et al.   BJU INTERNATIONAL

Defining response and non-response to treatment in patients with overactive bladder: a systematic review

(2013) Howard B. Goldman et al.   CURRENT MEDICAL RESEARCH AND OPINION

Global Prevalence and Economic Burden of Urgency Urinary Incontinence: A Systematic Review

(2013) Ian Milsom et al.   EUROPEAN UROLOGY

The medical management of refractory Overactive Bladder

(2013) Dudley Robinson et al.   MATURITAS

Changes in urinary nerve growth factor and prostaglandin E2 in women with overactive bladder after anticholinergics

(2012) Kang Jun Cho et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Clinical and urodynamic differences among women with overactive bladder according to the presence of detrusor overactivity

(2012) Seong Jin Jeong et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline

(2012) E. Ann Gormley et al.   JOURNAL OF UROLOGY

Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: A systematic review and meta-analysis

(2012) C. Burton et al.   NEUROUROLOGY AND URODYNAMICS

Transcutaneous electrical nerve stimulation: an effective treatment for refractory non-neurogenic overactive bladder syndrome?

(2012) Marc Tellenbach et al.   WORLD JOURNAL OF UROLOGY

Cost-effectiveness analysis of anti-muscarinic agents for the treatment of overactive bladder

(2012) Edward P. Armstrong et al.   JOURNAL OF MEDICAL ECONOMICS

Contemporary Management of Lower Urinary Tract Disease With Botulinum Toxin A: A Systematic Review of Botox (OnabotulinumtoxinA) and Dysport (AbobotulinumtoxinA)

(2011) Altaf Mangera et al.   EUROPEAN UROLOGY

Repeated Botulinum Toxin Type A Injections for Refractory Overactive Bladder: Medium-Term Outcomes, Safety Profile, and Discontinuation Rates

(2011) Christopher Dowson et al.   EUROPEAN UROLOGY

Botulinum toxin A submucosal injection for refractory non-neurogenic overactive bladder: Early outcomes

(2011) Kikuo Okamura et al.   INTERNATIONAL JOURNAL OF UROLOGY

Botulinum toxin outcomes for idiopathic overactive bladder stratified by indication: Lack of anticholinergic efficacy versus intolerability

(2011) Iryna Makovey et al.   NEUROUROLOGY AND URODYNAMICS

Gabapentin: A novel drug as add-on therapy in cases of refractory overactive bladder in children

(2011) M.S. Ansari et al.   Journal of Pediatric Urology

Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial

(2010) Roger Dmochowski et al.   JOURNAL OF UROLOGY

Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Sham Efficacy in the Treatment of Overactive Bladder Syndrome: Results From the SUmiT Trial

(2010) Kenneth M. Peters et al.   JOURNAL OF UROLOGY

Augmentation Enterocystoplasty in Overactive Bladder: Is There Still a Role?

(2010) Polina Reyblat et al.   Current Urology Reports

A candidate serum biomarker for bladder pain syndrome/interstitial cystitis

(2009) Daniel E. Rubio-Diaz et al.   ANALYST

Double Anticholinergic Therapy for Refractory Overactive Bladder

(2009) Stéphane Bolduc et al.   JOURNAL OF UROLOGY

Triple therapy in refractory detrusor overactivity: a preliminary study

(2009) Ricardo Natalin et al.   WORLD JOURNAL OF UROLOGY

Validation of a sham for percutaneous tibial nerve stimulation (PTNS)

(2008) Kenneth Peters et al.   NEUROUROLOGY AND URODYNAMICS